DelveInsight's Mismatch Repair Deficiency Market Insights report includes a comprehensive understanding of current treatment practices, mismatch repair deficiency emerging drugs, market share of ...

The urgent fix addresses a dangerous flaw that disabled USB keyboards and mice in recovery mode, exactly when users need them ...

NG-350A has received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a significant unmet medical need. The drug is an intravenously delivered ...

Scientists have found a way to supercharge the immune system’s T cells by blocking a protein called Ant2, essentially rewiring how these cells generate energy. This metabolic reprogramming makes them ...

aDepartment of General Surgery, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong, China bGuangdong Provincial Key Laboratory of Precision Medicine for ...

A retrospective study found that patients with mismatch repair (MMR)-deficient advanced or recurrent endometrial cancer had numerically longer overall survival (OS) than those with MMR-proficient ...

The collapse of an Upstate bridge on Monday put an exclamation point on officials’ need to fix the state’s aging infrastructure. The car-sized hole in a bridge over Lake Keowee in Pickens County ...

Up to 5% of patients with metastatic castration-resistant prostate cancer (mCRPC) harbour loss-of-function alterations in mismatch repair genes (dMMR) resulting in microsatellite instability (MSI-H).

Twenty-one pathogenic variants found in clinically relevant genes, with an enrichment in mismatch repair genes. HealthDay News — Mismatch repair (MMR) germline alterations are enriched among patients ...

Background: For locally advanced rectal cancer (LARC) with a deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H), particularly in patients not eligible for immunotherapy, the ...